Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative
Year: 2021
Type: article
Abstract: High Resolution Image Download MS PowerPoint Slide This report describes the development of an orally active analgesic that resolves inflammation and neuropathic pain without the addictive potential of opioids. EC5026 acts on the cytochrome P450 branch of the arachidonate cascade to stabilize epoxides of polyunsaturated fatty acids (EpFA), which are natural mediators that reduce pain, resolve inflammation, and maintain normal blood pressure. EC5026 is a slow-tight binding transition-state mimic that inhibits the soluble epoxide hydrolase (sEH) at picomolar concentrations. The sEH rapidly degrades EpFA; thus, inhibiting sEH increases EpFA in vivo and confers beneficial effects. This mechanism addresses disease states by shifting endoplasmic reticulum stress from promoting cellular senescence and inflammation toward cell survival and homeostasis. We describe the synthesis and optimization of EC5026 and its development through human Phase 1a trials with no drug-related adverse events. Additionally, we outline fundamental work leading to discovery of the analgesic and inflammation-resolving CYP450 branch of the arachidonate cascade.
Source: Journal of Medicinal Chemistry
Authors: Bruce D. Hammock, Cindy B. McReynolds, Karen Wagner, Alan Buckpitt, Irene Cortes-Puch, Glenn Croston, Kin Sing Stephen Lee, Jun Yang, William K. Schmidt, Sung Hee Hwang
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,000
Awards: Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain, sEH Inhibitors to Treat Neuropathic Pain, G3474668483, G4383194787, Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics, Development of an Oral Analgesic for Neuropathic Pain, sEH Inhibitors to Treat Neuropathic Pain
OpenAlex ID: W3127048941
